← Evidence map

ArticleCurrent medicinal chemistry2026

Patents on Xylazine, a Drug Adulterant of Clinical Concern.

Alessia CatalanoPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40849779